Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $4.23 in the prior trading day, Astria Therapeutics Inc (NASDAQ: ATXS) closed at $4.37, up 3.31%. In other words, the price has increased by $3.31 from its previous closing price. On the day, 0.87 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ATXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.49 and its Current Ratio is at 17.49. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $47.
On January 31, 2025, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $26.
On July 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $35.TD Cowen initiated its Buy rating on July 29, 2024, with a $35 target price.
Stock Price History:
Over the past 52 weeks, ATXS has reached a high of $12.92, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is -17.86%, while the 200-Day Moving Average is calculated to be -50.47%.
Shares Statistics:
A total of 56.43M shares are outstanding, with a floating share count of 46.42M. Insiders hold about 17.75% of the company’s shares, while institutions hold 86.50% stake in the company.
